Authorship and contributorship
The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) – why and what?
Article first published online: 12 SEP 2012
© 2012 Blackwell Publishing Ltd
The Clinical Respiratory Journal
Volume 6, Issue 4, pages 208–214, October 2012
How to Cite
Please cite this paper as: The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD) – why and what? Clin Respir J 2012; 6: 208–214., and .
JV drafted the manuscript; All authors contributed and approved the final manuscript.
Conflict of interest
JV and RRR have received honoraria from the pharmaceutical industry. A full list can be found on http://www.goldcopd.org. SSH is an employee of GOLD.
- Issue published online: 12 SEP 2012
- Article first published online: 12 SEP 2012
- Accepted manuscript online: 20 AUG 2012 07:40AM EST
- Manuscript Accepted: 15 AUG 2012
- Manuscript Revised: 12 AUG 2012
- Manuscript Received: 11 JUL 2012
- comorbidities ;
- COPD ;
- diagnosis ;
- exacerbations ;
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published a strategy for diagnosis and for management of chronic obstructive pulmonary disease (COPD) since 2001 and this has formed the basis for numerous national and regional guidelines.
We describe the background for the 2011 revision of the GOLD document.
The GOLD document is updated annually and revised every 5 years based on published research as well as an evaluation by an expert panel of how to best formulate and disseminate knowledge on COPD.
The GOLD 2011 revision states that spirometry is required for making a clinical diagnosis of COPD. At the same time, the document has less emphasis on spirometric evaluation of disease severity and launches a combined assessment taking symptoms, spirometry and history of exacerbations into account. This is matched with initial treatment for COPD where smoking cessation, pulmonary rehabilitation and physical activity in general are given high priority followed by pharmacologic treatment guided by the novel assessment scheme. Comorbidities are often present in COPD and the GOLD 2011 revision gives some guidance in how to manage these as well as how to manage COPD in the presence of comorbidities.
A more clinically oriented GOLD document will hopefully improve assessment and management of COPD.